| # | Drug | Count |
|---|---|---|
| 0 | TREPROSTINIL | 144 |
| 1 | SILDENAFIL CITRATE | 85 |
| 2 | MACITENTAN | 84 |
| 3 | TADALAFIL | 84 |
| 4 | AMBRISENTAN | 75 |
| 5 | FUROSEMIDE | 58 |
| 6 | SILDENAFIL | 58 |
| 7 | RIOCIGUAT | 53 |
| 8 | 0XYGEN | 49 |
| 9 | OXYGEN | 49 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PHENAZOPYRIDINE HYDROCHLORIDE | 1 | 0.0030 |
| 1 | SATRALIZUMAB | 5 | 0.0028 |
| 2 | EPOPROSTENOL | 25 | 0.0019 |
| 3 | SELEXIPAG | 49 | 0.0019 |
| 4 | RIOCIGUAT | 53 | 0.0016 |
| 5 | ASFOTASE ALFA | 16 | 0.0016 |
| 6 | DOCUSATE SODIUM 50 MG SENNOSIDES 8.6 MG | 1 | 0.0013 |
| 7 | SENNOSIDES 8.6MG AND DOCUSATE SODIUM 50MG | 1 | 0.0013 |
| 8 | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE | 1 | 0.0013 |
| 9 | MACITENTAN | 84 | 0.0012 |
| # | Drug class | Count |
|---|---|---|
| 0 | Prostacycline Vasodilator [EPC] | 162 |
| 1 | Endothelin Receptor Antagonist [EPC] | 157 |
| 2 | Phosphodiesterase 5 Inhibitor [EPC] | 120 |
| 3 | Loop Diuretic [EPC] | 63 |
| 4 | Soluble Guanylate Cyclase Stimulator [EPC] | 53 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 52 |
| 6 | Prostacyclin Receptor Agonist [EPC] | 49 |
| 7 | Platelet Aggregation Inhibitor [EPC] | 33 |
| 8 | Factor Xa Inhibitor [EPC] | 32 |
| 9 | Corticosteroid [EPC] | 29 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Prostacyclin Receptor Agonist [EPC] | 49 | 0.0019 |
| 1 | Soluble Guanylate Cyclase Stimulator [EPC] | 53 | 0.0016 |
| 2 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 16 | 0.0016 |
| 3 | Prostacycline Vasodilator [EPC] | 162 | 0.0012 |
| 4 | Prostacycline [EPC] | 1 | 0.0011 |
| 5 | Provitamin D2 Compound [EPC] | 27 | 0.0009 |
| 6 | Phosphodiesterase 5 Inhibitor [EPC] | 120 | 0.0009 |
| 7 | Endothelin Receptor Antagonist [EPC] | 157 | 0.0008 |
| 8 | Paramagnetic Contrast Agent [EPC] | 2 | 0.0004 |
| 9 | Pyridone [EPC] | 11 | 0.0003 |